So while the IEA may attempt to stage a dramatic intervention designed to shock the market into submission, the underlying physics of oil supply remain unchanged. Global crude flows move on the scale ...

MannKind’s fair value estimate has been trimmed from US$9.61 to US$7.50, a roughly 22% cut that sets a more conservative anchor for the stock. This reset lines up with a split analyst backdrop, where ...

BLACKPINK's capsule drop is available on Complex.com from 12 noon ET on Thursday, March 5, through a partnership with the youth platform and Disney.

I am not going to pretend this is an FX story today. The EUR/USD take profit at 1.1550 quietly printed while I was asleep, which in this business is the closest thing to a polite exit you will ever ...

Umeclidinium-vilanterol is associated with improved clinical outcomes in symptomatic patients with chronic obstructive pulmonary disease.

So thank you, everyone, for joining us in the room and online at TD Cowen's 46th Annual Healthcare Conference. I'm Joe Thome, one of the senior biotech analysts here on the team at TD Cowen. And it is ...

From everyday essentials to big-ticket splurges, you’ll find loads of actually good deals, including 25% off an ingenious portable carpet cleaner sans cords, a whopping 60% off a versatile set of ...

MannKind (NASDAQ:MNKD) reaches a 1-year low, with its performance in Nasdaq Futures influencing broader biopharma market trends.

Plans to License or Monetize our Migraine and Inhalation Assets Continue FRAMINGHAM, Mass., Feb. 26, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") ...

United Therapeutics (NASDAQ:UTHR) used its fourth-quarter 2025 corporate update webcast to highlight what executives described as a set of near-term product and clinical milestones aimed at reshaping ...

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for about three months, a new study has revealed. This research by The University ...